Koninklijke Philips N.V. PHIA.AS
NL · Euronext Amsterdam · XAMS · stock · Healthcare · website
Koninklijke Philips N.V. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €17.8B | €18.0B | €18.2B | €17.8B |
| Gross profit | €8.1B | €7.8B | €7.4B | €7.2B |
| R&D expense | €1.7B | €1.7B | €1.9B | €2.1B |
| SG&A expense | €5.0B | €5.1B | €5.1B | €5.3B |
| Operating income | €1.4B | €513.0M | -€168.0M | -€177.0M |
| Interest expense | €294.0M | €337.0M | €306.0M | €244.0M |
| Income tax | €282.0M | €963.0M | -€73.0M | -€113.0M |
| Net income | €895.0M | -€702.0M | -€466.0M | -€1.6B |
| EPS (diluted) | €0.94 | €-0.75 | €-0.49 | €-1.68 |
| Operating cash flow | €1.2B | €1.6B | €2.1B | -€173.0M |
| Free cash flow | €504.0M | €893.0M | €1.5B | -€979.0M |
| Cash & equivalents | €2.8B | €2.4B | €1.9B | €1.2B |
| Inventory | €2.9B | €3.2B | €3.5B | €4.0B |
| Goodwill | €9.3B | €10.4B | €9.9B | €10.2B |
| Total assets | €26.9B | €29.0B | €29.4B | €30.7B |
| Total debt | €7.8B | €7.5B | €7.3B | €7.3B |
| Total liabilities | €16.0B | €16.9B | €17.3B | €17.4B |
| Shareholders' equity | €11.0B | €12.0B | €12.0B | €13.2B |
| Share buybacks | €0 | €411.0M | €662.0M | €187.0M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -1.0% | -0.8% | +1.9% | — |
| Free cash flow growth | -43.6% | -40.1% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · NL · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.